2025 Q4 -tulosraportti
20 päivää sitten
‧36 min
0,60 NOK/osake
Irtoamispäivä 6.5.
1,03%Tuotto/v
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 7 | - | - | ||
| 59 | - | - | ||
| 43 | - | - | ||
| 43 | - | - | ||
| 84 | - | - |
Ylin
39VWAP
Alin
37,5VaihtoMäärä
0,7 18 500
VWAP
Ylin
39Alin
37,5VaihtoMäärä
0,7 18 500
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 11.2. | ||
2025 Q3 -tulosraportti 23.10.2025 | ||
2025 Q2 -tulosraportti 10.7.2025 | ||
2025 Q1 -tulosraportti 7.5.2025 | ||
2024 Q4 -tulosraportti 12.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·19.2. · MuokattuGood to get a bit more turnover in the share, almost 4 million today is quite a lot for Gentian. Not just anyone either. Forced sale? Gentian Diagnostics: CTO buys shares, companies pull out today 10:50 AM ∙ News summary (AI) Gentian Diagnostics has recently experienced significant changes in its ownership structure. The company's Chief Technology Officer (CTO), Frank Frantzen, showed confidence by increasing his personal stake through a significant share purchase. At the same time, two investment companies, SKØIEN AS and DUKAT AS, are no longer listed among the company's shareholders, which indicates a sale of their holdings. CTO Frank Frantzen bought 3,115 shares in Gentian Diagnostics at an average price of NOK 40.0 per share. After this transaction, CTO Frank Frantzen now owns a total of 23,115 shares and 50,000 options in the company. The investment company SKØIEN AS has left the list of Gentian Diagnostics' shareholders. https://e24.no/boers-og-finans/i/kw2Q29/ny-smell-for-investor-tore-aksel-voldberg-selskapets-aksjekapital-er-tapt
·13.2.Not long ago, an analyst on Hegnar-TV highlighted this stock as the best case this year. The price was then at 58 kr.. I have at least bought some today.·19.2.Why does one believe Dukat has such enormous insight then? https://e24.no/boers-og-finans/i/kw2Q29/ny-smell-for-investor-tore-aksel-voldberg-selskapets-aksjekapital-er-tapt
·19.2.High risk and bad luck? I think one should know the market and Gentian's products to know what one is doing here
·13.2.New insider purchase 100000 kr·13.2.It looks like everyone is buying for 40kr a share. Is Vatne pressured to sell, I wonder?- ·12.2.A major problem with Gentian's stock is how lightly traded it has been, which has made it difficult to know how real the pricing has been lately. Today's fall shows the danger of relying excessively on the pricing of an illiquid stock from day to day, but I must say it reminds a bit of a forced sale when such a rough transaction as this is made.
·13.2.There were expectations that NT-proBNP would have boosted revenues in the coming years. The pricing of the stock before this share price drop was therefore completely OK. Now, the development of NT-proBNP is being postponed, but not given up. The share price drop is therefore very exaggerated. Furthermore, Gentian has other exciting things going on together with a large global diagnostics company. - ·12.2.Why is it collapsing? Looking at previous patterns, in these deep valleys there is a rebound + CFO bought for 120.000 kr just now
·12.2.Let's hope for a rebound tomorrow???·13.2.Remember the three-day rule in the stock market :) It's not always worth betting on a rebound the next day.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
20 päivää sitten
‧36 min
0,60 NOK/osake
Irtoamispäivä 6.5.
1,03%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·19.2. · MuokattuGood to get a bit more turnover in the share, almost 4 million today is quite a lot for Gentian. Not just anyone either. Forced sale? Gentian Diagnostics: CTO buys shares, companies pull out today 10:50 AM ∙ News summary (AI) Gentian Diagnostics has recently experienced significant changes in its ownership structure. The company's Chief Technology Officer (CTO), Frank Frantzen, showed confidence by increasing his personal stake through a significant share purchase. At the same time, two investment companies, SKØIEN AS and DUKAT AS, are no longer listed among the company's shareholders, which indicates a sale of their holdings. CTO Frank Frantzen bought 3,115 shares in Gentian Diagnostics at an average price of NOK 40.0 per share. After this transaction, CTO Frank Frantzen now owns a total of 23,115 shares and 50,000 options in the company. The investment company SKØIEN AS has left the list of Gentian Diagnostics' shareholders. https://e24.no/boers-og-finans/i/kw2Q29/ny-smell-for-investor-tore-aksel-voldberg-selskapets-aksjekapital-er-tapt
- ·13.2.Not long ago, an analyst on Hegnar-TV highlighted this stock as the best case this year. The price was then at 58 kr.. I have at least bought some today.·19.2.Why does one believe Dukat has such enormous insight then? https://e24.no/boers-og-finans/i/kw2Q29/ny-smell-for-investor-tore-aksel-voldberg-selskapets-aksjekapital-er-tapt·19.2.High risk and bad luck? I think one should know the market and Gentian's products to know what one is doing here
- ·13.2.New insider purchase 100000 kr·13.2.It looks like everyone is buying for 40kr a share. Is Vatne pressured to sell, I wonder?
- ·12.2.A major problem with Gentian's stock is how lightly traded it has been, which has made it difficult to know how real the pricing has been lately. Today's fall shows the danger of relying excessively on the pricing of an illiquid stock from day to day, but I must say it reminds a bit of a forced sale when such a rough transaction as this is made.·13.2.There were expectations that NT-proBNP would have boosted revenues in the coming years. The pricing of the stock before this share price drop was therefore completely OK. Now, the development of NT-proBNP is being postponed, but not given up. The share price drop is therefore very exaggerated. Furthermore, Gentian has other exciting things going on together with a large global diagnostics company.
- ·12.2.Why is it collapsing? Looking at previous patterns, in these deep valleys there is a rebound + CFO bought for 120.000 kr just now·12.2.Let's hope for a rebound tomorrow???·13.2.Remember the three-day rule in the stock market :) It's not always worth betting on a rebound the next day.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 7 | - | - | ||
| 59 | - | - | ||
| 43 | - | - | ||
| 43 | - | - | ||
| 84 | - | - |
Ylin
39VWAP
Alin
37,5VaihtoMäärä
0,7 18 500
VWAP
Ylin
39Alin
37,5VaihtoMäärä
0,7 18 500
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 11.2. | ||
2025 Q3 -tulosraportti 23.10.2025 | ||
2025 Q2 -tulosraportti 10.7.2025 | ||
2025 Q1 -tulosraportti 7.5.2025 | ||
2024 Q4 -tulosraportti 12.2.2025 |
2025 Q4 -tulosraportti
20 päivää sitten
‧36 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 11.2. | ||
2025 Q3 -tulosraportti 23.10.2025 | ||
2025 Q2 -tulosraportti 10.7.2025 | ||
2025 Q1 -tulosraportti 7.5.2025 | ||
2024 Q4 -tulosraportti 12.2.2025 |
0,60 NOK/osake
Irtoamispäivä 6.5.
1,03%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·19.2. · MuokattuGood to get a bit more turnover in the share, almost 4 million today is quite a lot for Gentian. Not just anyone either. Forced sale? Gentian Diagnostics: CTO buys shares, companies pull out today 10:50 AM ∙ News summary (AI) Gentian Diagnostics has recently experienced significant changes in its ownership structure. The company's Chief Technology Officer (CTO), Frank Frantzen, showed confidence by increasing his personal stake through a significant share purchase. At the same time, two investment companies, SKØIEN AS and DUKAT AS, are no longer listed among the company's shareholders, which indicates a sale of their holdings. CTO Frank Frantzen bought 3,115 shares in Gentian Diagnostics at an average price of NOK 40.0 per share. After this transaction, CTO Frank Frantzen now owns a total of 23,115 shares and 50,000 options in the company. The investment company SKØIEN AS has left the list of Gentian Diagnostics' shareholders. https://e24.no/boers-og-finans/i/kw2Q29/ny-smell-for-investor-tore-aksel-voldberg-selskapets-aksjekapital-er-tapt
- ·13.2.Not long ago, an analyst on Hegnar-TV highlighted this stock as the best case this year. The price was then at 58 kr.. I have at least bought some today.·19.2.Why does one believe Dukat has such enormous insight then? https://e24.no/boers-og-finans/i/kw2Q29/ny-smell-for-investor-tore-aksel-voldberg-selskapets-aksjekapital-er-tapt·19.2.High risk and bad luck? I think one should know the market and Gentian's products to know what one is doing here
- ·13.2.New insider purchase 100000 kr·13.2.It looks like everyone is buying for 40kr a share. Is Vatne pressured to sell, I wonder?
- ·12.2.A major problem with Gentian's stock is how lightly traded it has been, which has made it difficult to know how real the pricing has been lately. Today's fall shows the danger of relying excessively on the pricing of an illiquid stock from day to day, but I must say it reminds a bit of a forced sale when such a rough transaction as this is made.·13.2.There were expectations that NT-proBNP would have boosted revenues in the coming years. The pricing of the stock before this share price drop was therefore completely OK. Now, the development of NT-proBNP is being postponed, but not given up. The share price drop is therefore very exaggerated. Furthermore, Gentian has other exciting things going on together with a large global diagnostics company.
- ·12.2.Why is it collapsing? Looking at previous patterns, in these deep valleys there is a rebound + CFO bought for 120.000 kr just now·12.2.Let's hope for a rebound tomorrow???·13.2.Remember the three-day rule in the stock market :) It's not always worth betting on a rebound the next day.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 7 | - | - | ||
| 59 | - | - | ||
| 43 | - | - | ||
| 43 | - | - | ||
| 84 | - | - |
Ylin
39VWAP
Alin
37,5VaihtoMäärä
0,7 18 500
VWAP
Ylin
39Alin
37,5VaihtoMäärä
0,7 18 500
Välittäjätilasto
Dataa ei löytynyt